Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant Topoisomerase II alpha anticorps (AA 1352-1493)

Cet anticorps Souris Monoclonal détecte spécifiquement Topoisomerase II alpha dans IHC (f). Il présente une réactivité envers Humain.
N° du produit ABIN7127010

Aperçu rapide pour Recombinant Topoisomerase II alpha anticorps (AA 1352-1493) (ABIN7127010)

Antigène

Voir toutes Topoisomerase II alpha (TOP2A) Anticorps
Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 142
  • 63
  • 32
  • 5
  • 5
  • 3
  • 3
  • 3
  • 1
Humain

Hôte

  • 105
  • 38
Souris

Clonalité

  • 92
  • 51
Monoclonal

Conjugué

  • 79
  • 9
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Topoisomerase II alpha est non-conjugé

Application

  • 101
  • 61
  • 52
  • 47
  • 23
  • 19
  • 15
  • 8
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Épitope

    • 17
    • 15
    • 10
    • 10
    • 8
    • 7
    • 7
    • 6
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1352-1493

    Specificité

    It recognizes a 170 kDa protein, which is identified as topoisomerase IIi±. It shows no cross-reaction with Topoisomerase II i² or I. Topo II i± plays important roles in synthesis and transcription of DNA as well as chromosomal segregation during mitosis. It is reported to be a sensitive and specific marker of late S-, G2- & M-phases in transformed and developmentally regulated normal cells. Topo II i± is also implicated in drug resistance of tumor cells and has been shown to be over-expressed in many human cancers. Decreased expression of Topo IIa is the predominant mechanism of resistance to several chemotherapeutic agents.

    Réactivité croisée (Details)

    Human and Mouse.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant human Topoisomerase II alpha fragment (aa1352-1493)

    Isotype

    IgG1
  • Indications d'application

    Known_Application: Immunohistochemistry (Formalin-fixed) (0.5-1 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Human lymph node or tonsil.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

    Autre désignation

    TOP2A

    Sujet

    ATP hydrolyzing DNA topoisomerase II alfa, DNA gyrase, DNA topoisomerase (ATP hydrolyzing), DNA topoisomerase 2 alpha, DNA topoisomerase II 170kD, DNA topoisomerase II alpha, DNA Topoisomerase2, TOP2A, Topoisomerase DNA II alpha 170 kDa, TP2A,Topoisomerase II alpha (Proliferation & Drug-Resistance Marker)
    Cellular localisation: Nuclear

    Poids moléculaire

    170kDa

    ID gène

    7153, 156346

    UniProt

    P11388

    Pathways

    Cycle Cellulaire, Mitotic G1-G1/S Phases
Vous êtes ici:
Chat with us!